MBX in the 13F filings
MBX Biosciences Inc · CUSIP 55287L101
- Quarter end
- 31 Mar 2026
- the date the book describes
- Filed
- 18 May 2026
- latest of these filings; the earliest 12 May 2026
- Managers listing it
- 19
- at least, of 95 tracked, among listed positions
- Comparable managers
- 91
- filed both Q4 2025 and Q1 2026; 1 listed it in both
- Shares listed
- 10,394,853
- combined, among listed positions
- Reported value
- $310m
- combined, at the quarter end
AllianceBernstein LP. Values in this filing are at the previous quarter end's prices; its share count is the quarter end's.
Among the 91 comparable managers: 9 buyers (opened or added shares) and 15 sellers (trimmed or exited), at least, among listed positions. Their net change in shares was +1,626,978.
Managers listing MBX in Q1 2026
19 of 19 holders
Largest increases and reductions, by shares
Increases
- Fidelity (FMR LLC)existing position · 2,936,684 shares now+2,920,938
- T. Rowe Price Associates Incexisting position · 1,029,007 shares now+188,501
- Citadel Advisors LLCexisting position · 932,833 shares now+122,976
- Millennium Management LLCexisting position · 564,415 shares now+102,366
- Marshall Wace LLPnew position · 62,703 shares now+62,703
Reductions
- D. E. Shaw & Co.existing position · 288,889 shares now-382,949
- Wellington Management Group LLPexisting position · 3,191,824 shares now-158,137
- Woodline Partners LPexisting position · 900,063 shares now-100,000
- Susquehanna International Group LLPexisting position · 9,487 shares now-67,041
- Verition Fund Management LLCexisting position · 10,222 shares now-47,353
New positions and exits
New (2)
Exited (5)
- Point72 Asset Management LPwas $21m
- Balyasny Asset Management LLCwas $3.8m
- Jane Street Group LLCwas $2.7m
- Renaissance Technologies LLCwas $1.0m
- Brevan Howard Capital Management LPwas $809k
Ownership over time
Tracked managers listing it, at least.
| Quarter | Holders | Reported value | Buyers | Sellers |
|---|---|---|---|---|
| Q3 2024 | 3 | $15m | 3 | 0 |
| Q4 2024 | 1 | $11m | 1 | 2 |
| Q1 2025 | 1 | $6.5m | 1 | 0 |
| Q2 2025 | 2 | $17m | 2 | 0 |
| Q3 2025 | 1 | $21m | 1 | 0 |
| Q4 2025 | 1 | $32m | 14 | 11 |
| Q1 2026 | 1 | $27m | 9 | 15 |
| Q2 2026 | 4 | $342m | 11 | 10 |
Compare with…
Holders over time, buyers and sellers, and the managers holding both, side by side for up to four stocks.
MBX and LLY →MBX and TMO →MBX and JNJ →Choose a stock to compare with MBX →
How much of the picture this is
A 13F is a manager’s long US-listed equity book at a quarter end, filed up to 45 days later. It shows no shorts, cash, bonds or performance, and it is never today’s portfolio. Large books are listed to their largest positions, so a manager missing from this table may still hold a small position below that line. These are 95 tracked managers, not the institutional market.
Which funds own MBX, latest filings →Back to the 13F Explorer →